The cell therapy market size is forecasted to increase by USD 21.061 billion from 2021 to 2026, at a CAGR of 56.79%, according to the recent market study by Technavio. The growth of the market will be driven by the increasing prevalence of chronic diseases, limitations in traditional organ transplantations fueling demand for cell therapies, and increasing funding in cell-based research. North America will account for 40% of the market growth during the forecast period. The growth of the regional
Mesoblast share price bleeds after chewing through $18.1 million fool.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com.au Daily Mail and Mail on Sunday newspapers.
These are the 10 most shorted ASX shares fool.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com.au Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ The cell therapy market size is forecasted to increase by USD 21.061 billion from 2021 to 2026, at a CAGR of 56.79%, according to the recent.
The Stem Cell Therapies Market is anticipated to increase from US$ 187 million in 2021 to US$ 401 million by 2026, at a CAGR of 16.7%, by 2032.The COVID-19 pandemic has caused severe impacts on the global economy at various levels and which can be seen on the Healthcare industry as well. The thriving market of healt.